Skip to main content
logo
Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
14.78
-0.99 (-6.28%)
At close: Aug 20, 2026, 4:00 PM EDT
15.07
+0.29 (1.96%)
After-hours: Aug 20, 2026, 4:21 PM EDT

Monte Rosa Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,2611,021426283368950
Market Cap Growth
347.74%139.48%50.74%-23.21%-61.22%-
Enterprise Value
678670228151142583
Last Close Price
15.7715.686.945.657.6120.42

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
44.198.265.64---
PB Ratio
2.764.381.911.581.362.73
P/TBV Ratio
2.614.381.911.581.362.73
P/FCF Ratio
--11.22---
P/OCF Ratio
--10.15---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
23.895.423.01---
EV/FCF Ratio
--6.00---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.080.170.190.260.17-
Debt / FCF Ratio
--1.12---
Net Debt / Equity Ratio
-1.20-1.45-1.48-1.04-0.79-1.00
Net Debt / EBITDA Ratio
3.367.374.511.361.994.89
Net Debt / FCF Ratio
18.1812.29-8.672.972.055.01
Asset Turnover
0.060.280.20---
Quick Ratio
10.496.052.375.0010.5820.80
Current Ratio
10.586.122.405.0710.7920.96
Return on Equity (ROE)
-42.66%-16.94%-36.15%-60.07%-35.06%-40.35%
Return on Assets (ROA)
-21.63%-7.64%-13.66%-27.72%-19.82%-21.92%
Return on Capital Employed (ROCE)
-28.80%-14.10%-28.80%-55.70%-35.50%-20.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-12.69%-3.78%-17.05%-47.85%-29.46%-7.79%
FCF Yield
-2.53%-2.69%8.91%-22.22%-28.61%-7.28%
Buyback Yield / Dilution
-11.90%-12.39%-43.80%-8.83%-88.91%-1548.09%
SEC Filings: 10-K · 10-Q